Global Bone and Mineral Diagnostic Testing Market 2015-2019

Table of Contents

•  Highlights

•  Market overview
•  Top-vendor offerings

•  Research methodology
•  Economic indicators

•  Key market highlights

•  Market overview
•  Market size and forecast
•  Five forces analysis

•  Current scenario: Validating diagnostic tests
•  Reimbursement structure in the US
•  Reimbursement structure in EU
•  Prevailing issues of reimbursement policies

•  Vitamin D testing
•  Bone metabolism

•  ELISA
•  CLIA
•  Other tests

•  Assays/consumables
•  Instruments

•  Bone and mineral diagnostic testing market in Americas
•  Bone and mineral diagnostic testing market in EMEA
•  Bone and mineral diagnostic testing market in APAC

•  Increasing incidence of bone disorders
•  Early diagnosis and preventive medicine
•  Increase in geriatric population

•  Pricing erosion in established countries
•  Limited detection capability and complexity
•  Reimbursement and regulatory hurdles

•  Development in automation of assays
•  Growing focus on emerging countries
•  Focus on POC diagnostic tests
•  Increase in awareness and role of government and non-profit institutions

•  Competitive scenario
•  Key vendor analysis 2014
•  Other prominent vendors

•  Abbott Diagnostics
•  bioMérieux
•  DiaSorin
•  Roche Diagnostics
•  Siemens Healthcare
•  Quidel

•  List of abbreviations